Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,406 | -34,151 | -21,031 | -14,349 | -8,223 |
| Depreciation Amortization | 52 | 238 | 177 | 122 | 61 |
| Accounts receivable | 392 | -1,883 | 37 | -951 | 75 |
| Accounts payable and accrued liabilities | -4,480 | 6,037 | 2,204 | 389 | 71 |
| Other Working Capital | -6,818 | 7,623 | 2,915 | -1,276 | 123 |
| Other Operating Activity | 5,319 | 1,467 | 2,914 | 5,166 | 2,752 |
| Operating Cash Flow | $-14,941 | $-20,669 | $-12,784 | $-10,899 | $-5,141 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -344 | -191 | -117 | -59 |
| Investing Cash Flow | $-132 | $-344 | $-191 | $-117 | $-59 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77 | 57,830 | 57,826 | N/A | N/A |
| Other Financing Activity | -128 | 8,150 | 8,150 | -1,368 | -171 |
| Financing Cash Flow | $-51 | $65,980 | $65,976 | $-1,368 | $-171 |
| Beginning Cash Position | 75,354 | 30,387 | 30,387 | 30,387 | 30,387 |
| End Cash Position | 60,230 | 75,354 | 83,388 | 18,003 | 25,016 |
| Net Cash Flow | $-15,124 | $44,967 | $53,001 | $-12,384 | $-5,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,941 | -20,669 | -12,784 | -10,899 | -5,141 |
| Capital Expenditure | -132 | -344 | -191 | -117 | -59 |
| Free Cash Flow | -15,073 | -21,013 | -12,975 | -11,016 | -5,200 |